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1. INTRODUCTION
Since long organophosphate (OP) compounds have 
been extensively used as insecticides (malathion, parathion, 
diazinon, fenthion, dichlorvos, chlorpyrifos, etc.) and herbicides 
(tribufos, merphos, etc.). OPs also find wide applications in 
the industry (plasticizers, antioxidants, softening agents, flame 
retardants, gasoline additives, etc.) and medical management 
of Myasthenia gravis and Glaucoma1-3. Extensive use of these 
compounds is responsible for various accidental and intentional 
exposures causing morbidity and mortality. Additionally, OP 
nerve agents (soman, sarin, tabun, VX, etc.) have been widely 
used in chemical warfare. Use of such agents in terrorism has 
escalated in the recent past, which is a matter of concern to 
both civil and military authorities4-7. 
Toxicity of OPs is primarily attributed to irreversible 
inhibition of acetylcholinesterase (AChE) enzyme at the 
cholinergic synapses. This results in the accumulation of 
acetylcholine (ACh), a neurotransmitter at the synaptic junction 
causing overstimulation and subsequent disruption of nerve 
impulse transmission in both central and peripheral nervous 
system. The cholinergic crisis involves various muscarinic, 
nicotinic and central effects1,4,6. The current treatments of OP 
poisoning like atropine and pralidoxime (2-PAM) are intended 
to alleviate such effects8. 
Signs and symptoms of OP poisoning are predictable 
and intensely correlate with AChE activity7. However, OP 
toxicity is not mediated through cholinergic crisis alone. There 
are observed changes in non-cholinergic markers as well, 
which usually exacerbate the OP toxicity and complicate the 
diagnosis. These changes possibly could occur as secondary 
manifestations of cholinergic crisis9. Such effects include 
altered blood gas analysis, hypokalemia, hyperglycemia, acute 
pancreatitis, proteinuria, altered liver and kidney function test, 
etc. OP- induced generation of reactive oxygen species (ROS) 
leading to lipid peroxidation, oxidative stress and programmed 
cell death are also reported10-14. Usually the bed side tests to 
confirm OP poisoning include measurement of blood AChE 
and butyrylcholinesterase (BChE) activity10. Other techniques 
like detection of OP-adducts and antibodies have also been 
explored to confirm OP poisoning11. Measurement of plasma 
β-glucoronidase (BG) activity is also suggested as a biomarker 
of OP poisoning15,16. In the absence of a comprehensive 
study17, we report here the acute effect of diisopropyl 
phosphorofluoridate (DFP) on AChE, BChE and BG activity 
in soft tissues of mice. Also, reduced glutathione (GSH) and 
malondialdehyde (MDA) levels were measured to assess 
oxidative stress, together with DNA damage in brain (agarose 
gel electrophoresis) and blood (comet assay). DFP is an anti-
cholinesterase (OP) agent with structural similarity with Sarin, 
and is widely used as a simulant of nerve agent in experimental 
OP poisoning18,19. 
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2. MATERIALS AND METHODS
2.1 Chemicals and Reagents
Ethylenediaminetetraacetic acid (EDTA), Trizma 
base,  o-phthaldialdehyde (OTP), Triton X-100, dimethyl 
sulfoxide (DMSO), acetylthiocholine iodide, 5, 5’-Dithiobis-
(2-nitrobenzoic acid) (DTNB), phenolphthalein mono-β-
glucosiduronic acid, 2-thiobarbituric acid (TBA), ethidium 
bromide, sodium dodecyl sulphate (SDS), and normal melting 
point agarose (NMPA) were purchased from Sigma-Aldrich 
Inc. (St. Louis, USA). DFP (> 99 per cent purity), low melting 
point agarose (LMPA), and all other chemicals, reagents and 
buffers of highest purity were procured from Merck India Ltd. 
(Mumbai, India).
2.2 Animals
Male Swiss Albino mice (25 g - 30 g) were procured from 
the animal facility of Defence research and Development 
Establishment (DrDE), Gwalior. The animals were housed 
in polypropylene cages on dust free rice husk as the bedding 
material with free access to food (Ashirwad Brand, Chandigarh, 
India) and water ad libitum. They were maintained in controlled 
environmental conditions of ambient temperature (22 ± 2 °C) 
and relative humidity of 40-60 per cent in a 12:12 light: dark 
cycle. The care and maintenance of the animals were as per 
the approved guidelines of the Committee for the Purpose 
of Control and Supervision of Experiments on Animals 
(CPCSEA), Ministry of Environment and Forest, Govt. of 
India, New Delhi. Animal experiments were carried out with the 
approval of Institutional Animal Ethical Committee of DrDE.
2.3 Treatment
The acute (24 h) median lethal dose (LD50) of DFP by 
subcutaneous (s.c.) route in mice was found to be 3.86 (2.48 
- 6.12) mg/kg. Values in parenthesis are fiducial limits at 95 
per cent confidence interval (our unpublished work). A total 
of one hundred and eighty two animals were randomised and 
used for the present study. Initially 170 animals were divided 
into four groups of thirty and one group of fifty animals each 
as follows: (1) Control; n= 30, (2) 0.125 LD50 DFP; n= 30, (3) 
0.25 LD50 DFP; n= 30, (4) 0.50 LD50 DFP; n= 30, and (5) 1.0 
LD50 DFP; n= 50. In group 5 only, the surviving animals (n = 
6) were considered for the study. Additional two groups (2.0 and 
4.0 LD50 DFP) of six animals each were included in BG assay 
studies alone. Control animals received equivalent amount of 
carrier (10 per cent PG-NS; normal saline- propylene glycol). 
Animal body weight was recorded daily and blood was collected 
from the retro-orbital plexus of ether anesthetised animal at 1 h, 4 
h, 24 h, 7 d, and 14 d post-exposure, using heparinised capillary. 
Blood was used for comet assay or single cell gel electrophoresis 
(SCGE) and measurement of BChE and BG activity in plasma. 
Thereafter, animals were killed by cervical dislocation and 
the brain was excised quickly. The brain was rinsed in 0.9 per 
cent saline, blotted and weighed to determine the Organ-Body 
Weight Index (OBI). The OBI (Brain) was calculated as the ratio 
of brain weight X 100/ animal body weight. 
2.4 BChE and AChE Estimation
Cholinesterase activity in blood plasma and brain tissue 
homogenate were determined by the method of Ellman20 , et al. 
For the measurement of AChE, a 10 per cent brain homogenate 
was prepared in enzymatic buffer using tissue rupter for 3 min 
- 5 min at 4 °C. In this method, 2.840 ml phosphate buffer (pH 
8.0), 10 µl of sample and 100 µl DTNB were mixed. reaction 
was started by adding 50 µl of 0.075 M acetylthiocholine iodide 
and change in absorbance per minute was recorded for four 
minute duration at 410 nm using a micro plate reader (BioTek, 
USA). For the measurement of plasma BChE a 10 µl enzyme 
source was taken. The plasma BChE and brain AChE activities 
were expressed as µmol acetylthiocholine hydrolysed/min/ml 
blood and µmol acetylthiocholine hydrolysed/min/g wet tissue, 
respectively.
2.5 BG Estimation 
The amount of BG released in plasma was measured 
by the method of Fishman21, et al. Measurement of BG 
activity was initiated by adding 100 µl of 6 mM substrate 
(phenolphthalein mono β-glucosiduronic acid) in 100 µl of 0.2 
M sodium acetate buffer which was followed by addition of 50 
µl of sample. Above mixture was kept at 37 °C in incubator for 
4 h after which 0.75 ml H2O and 0.5 ml glycine NaOH buffer 
(200 mM; pH 11.7) containing 0.2 per cent SDS was added. 
Centrifugation of the above samples was done at 1000 g for 15 
min and absorbance of supernatant was measured at 540 nm on 
a micro plate reader.
2.6 GSH Estimation
GSH levels were assayed in tissue homogenate following 
the method of Hissin and Hilf22. Briefly, 1.5 per cent homogenate 
was prepared in 1.92 ml phosphate EDTA buffer (pH 8.0), to this 
0.5 ml MPA (metaphosphoric acid) was added and centrifuged 
at 6000 rpm for 15 min. To 0.25 ml of the supernatant 2.25 
ml of phosphate EDTA buffer was added, from which 0.1 ml 
solution was taken and 1.8 ml of phosphate EDTA buffer and 
0.1 ml of OPT were added. The cocktail was incubated for 15 
min (in dark) at room temperature. Fluorescence was measured 
at excitation 350 nm and emission 420 nm and values were 
expressed as µmol/g wet tissue.
2.7 MDA Estimation
To assess the amount of lipid peroxidation, MDA levels in 
brain tissue was  assayed following the method of Okhawa23, 
et al. Briefly, a 10 per cent tissue homogenate (in 1.15 per cent 
KCl) was prepared and centrifuged for 10 min at 6000 rpm. 
To 0.1 ml of above supernatant, 0.2 ml of 8.1 per cent SDS 
was added, followed by the addition of 1.5 ml of 20 per cent 
acetic acid (pH 3.5) and 1.5 ml of 0.8 per cent TBA, this was 
followed by boiling at 95 °C for 1 h, cooled and centrifuged at 
6000 rpm for 15 min. The supernatant was separated and its 
absorbance measured spectrophotometrically at 532 nm, and 
the values expressed as n moles MDA/ g wet tissue.
2.8 Comet Assay
Comet assay was performed by the method of Singh24, et al. 
with some minor modifications. Microscopic slides were 
washed using 10 per cent chromic acid. Dust free slides were 
then dipped in 1 per cent NMPA and allowed to solidify. 10 per 
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cent whole blood was mixed with 1 per cent LMPA and poured 
onto the slides. Slides were covered with cover slips and kept 
on ice for 10 min. Cover slips were removed and second layer 
of 1 per cent LMPA was added onto the slides which were 
again covered with new cover slips on ice. After 10 min, cover 
slips were removed and slides were dipped in cell lysis buffer 
(2.5 M NaCl, 100 mM EDTA, 10 mM Trizma base, 1 per cent 
Triton X-100 and 10 per cent DMSO) and kept at 4 °C  for 2 h. 
The above procedure was performed in dark to minimize DNA 
damage. After 2 h, slides were removed from lysis buffer and 
excess buffer was removed from surface. Thereafter, the slides 
were processed for electrophoresis. Slides were incubated in 
running buffer (10 N NaOH, 200 mM EDTA) for 30 min to 
unwind DNA. Electrophoresis of slides was carried out at 24 
V and 300 mA for 30 min. Slides were then placed on a dry 
surface and neutralisation buffer (0.4 M Tris, pH 7.5) were 
added on slides for 3 times at interval of 5 min. Slides were 
then stained with ethidium bromide for 5 min and washed 
with chilled distilled water. Cover slips were placed and slides 
were scored immediately at 40x under fluorescent microscope 
(Leica, Germany) for the visualisation of image.
2.9 DNA Isolation and Fragmentation
DNA isolation and fragmentation assay was performed 
by phenol:chloroform method of Sambrook and Russell25. 
DNA isolated from a 10 per cent brain homogenate was 
electrophoresed on 1.2 per cent agarose gel impregnated with 
ethidium bromide; 1 kb DNA served as standard. Gel was 
visualised under UV gel imaging system (FluorChemTM SP, 
Alpha-Innotech, USA).
2.10  Data analysis
The results are expressed as mean ± SEM (n=6). The data 
were analysed by one-way analysis of variance (ANOVA) 
followed by Dunnet’s test. Statistical significance was drawn 
at *p < 0.05 and **p < 0.01 levels using Sigma Stat software 
(Jandel Scientific Inc., CA, USA).
3. RESULTS
3.1  Animal Body Weight
The dose and time- dependent effect of DFP on mice body 
weight is depicted in Fig. 1. Animals received s.c. injection of 
various doses of DFP and were monitored for animal weight gain 
from 0 d to 14 d. Control animals received equivalent amount 
of carrier (PG-NS). Each group comprised of 6 animals, except 
DFP 1.0 LD50 group, where 10 animals were treated and only 
6 surviving animals were included in the experiment. The data 
show that none of the treatments exhibited any adverse effect 
on animal body weight gain and all the treatment groups were 
comparable to control. Animal weight in control groups usually 
varied between 27.0 ± 0.83 g and 31.0 ± 2.3 g. 
3.2 Organ-Body Weight Index (Brain)
Figure 2 illustrates the OBI (brain) in different treatment 
groups at various time intervals. None of the treatments 
exerted any deleterious effect on OBI (brain) when compared 
to control, which in case of control animals varied between 
1.16 ± 0.04 and 1.25 ± 0.02. 
3.3  BChE and AChE Activity
DFP- induced dose and time- dependent plasma BChE 
inhibition is shown Fig. 3. All the doses of DFP significantly 
(p< 0.01) inhibited the enzyme activity up to 24 h post exposure 
compared to control. The mean enzyme activity in control 
plasma was 3.47±0.18 µmol acetylthiocholine hydrolysed/ 
min/ ml blood. Maximum BChE inhibition of 98 per cent was 
observed in 1.0 LD50 DFP at 1 h, which progressively decreased 
to 68 per cent by 24 h. Similarly, 0.125 LD50 DFP showed 
91 per cent inhibition at 1 h, which progressively tapered to 
37 per cent by 24 h. A conspicuous dose and time-dependent 
inhibition of the enzyme was observed. With the passage of 
time, a progressive reactivation of the enzyme was visible in 
all the treatment groups, and enzyme activity was found to 
normalize by 7 d post exposure. Figure 4 shows the dose and 
time- dependent effect of DFP on brain AChE activity. The data 
Figure 1. Effect of DFP on body weight of mice. Animals received 
various doses of DFP (s.c.). Control animals received 
equivalent amount of carrier. Values are mean ± SEM 
(n= 6). 
Figure 2.  Effect of DFP on organ-body weight index (brain) of 
mice. Animals received various doses of DFP (s.c.). 
Control animals received equivalent amount of carrier. 
Values are mean ± SEM (n= 6). 
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reveal a noticeable dose and time- dependent inhibition of the 
enzyme up to 7 d post exposure. The mean enzyme activity in 
control brain homogenate was estimated to be 7.32 ± 0.23 µmol 
acetylthiocholine hydrolysed/ min/ g wet tissue. Maximum 
AChE inhibition of 92 per cent was observed in 1.0 LD50 DFP 
at 1 h, which progressively decreased to 54 per cent by 7 d. 
Similarly, 0.125 LD50 DFP showed 36 per cent inhibition at 
1 h, which progressively decreased to 8 per cent by 7 d. AChE 
inhibition in 0.25 LD50 and 0.125 LD50 DFP was not significant 
compared to control after 24 h, while the enzyme in 1.0 LD50 
and 0.50 LD50 group remained significantly inhibited up to 7 
d. The enzyme activity in all the treatment groups was found to 
normalize by 14 d post exposure. 
3.4 BG Activity
A dose and time- dependent effect of DFP on plasma BG 
activity in mice is illustrated in Fig. 5. None of the treatments at 
0.125 LD50 - 0.50 LD50 DFP produced any change in plasma 
BG levels at any time point. However, in 1.0 LD50 group at 
1 h alone, a significant (p<0.05) increase in BG activity was 
observed compared to control. When the dose of DFP was 
further raised to 2.0 LD50 and 4.0 LD50, the BG levels were 
found to be elevated further in a dose-dependent manner. In 
these groups all the animals were bled immediately prior to 
death (10 min - 15 min). Here, the increase in BG levels was 
visible at 1 h post exposure alone. 
Figure 3.  Effect of DFP on plasma butyrylcholinesterase activity 
of mice. Animals received various doses of DFP (s.c.). 
Control animals received equivalent amount of carrier. 
Values are mean ± SEM (n= 6). Statistically significant 
at **p< 0.01 compared to corresponding control. 
Figure 4. Effect of DFP on brain acetylcholinesterase activity 
of mice. Animals received various doses of DFP 
(s.c.). Control animals received equivalent amount of 
carrier. Values are mean ± SEM (n= 6). Statistically 
significant at **p< 0.01 compared to corresponding 
control. 
Figure 5.  Effect of DFP on plasma β -glucuronidase activity 
of mice. Animals received various doses of DFP 
(s.c.). Control animals received equivalent amount of 
carrier. Additional groups of 2.0 and 4.0 LD50 DFP 
were included here, where the animals were bled just 
prior to death (10 min - 15 min). Values are mean ± 
SEM (n= 6). Statistically significant at *p< 0.05 and 
**p< 0.01 compared to corresponding control. 
3.5 GSH and MDA Levels
Figure 6 depicts the GSH levels in brain homogenate 
after various treatments. All the doses of DFP significantly 
diminished the GSH levels at 1 h. However, significant 
decrease compared to corresponding control was visible up to 
24 h post exposure after 0.50 LD50 and 1.0 LD50 DFP alone. 
No appreciable dose or time-dependent effect was visible. GSH 
levels in DFP treated groups were found to be comparable to 
control after 7 d. MDA levels in brain homogenate after various 
treatments are shown in Fig. 7. The MDA levels were found to 
be significantly elevated (p<0.05) in 0.5 LD50 and 1.0 LD50 
DFP at 4 h post exposure alone. No significant change in MDA 
levels was observed in any other dose or time point.
3.6 DNA Damage 
The comet assay or SCGE was performed in mice 
blood from all the treatment groups at all the time points. 
Representative images of lymphocyte comets from control and 
1.0 LD50 DFP treated group after 14 d exposure are depicted in 
Fig. 8 (a) and 8 (b), respectively. On the basis of product of tail 
length and relative tail intensity, no significant difference was 
observed between control and DFP treated groups, thereby not 
TIME INTErVALS
TIME INTErVALS
TIME INTErVALS
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indicating any DNA damage. Figure 9 represents the agarose 
gel electrophoresis for qualitative analysis of DNA extracted 
from whole brain homogenate of mice receiving various 
treatments after 14 d of exposure. Comparison of control gel 
with 0.125 LD50 - 1.0 LD50 DFP did not show any change in 
gel pattern indicating that none of the treatments caused any 
necrotic or apoptotic kind of DNA damage.
4. DISCUSSION
Identification of different biomarkers is crucial for 
correctly establishing the exposure of poison. At the same 
time, it is equally important to characterise such biomarker 
for designing appropriate therapeutic measures. Blood 
cholinesterases (AChE and BChE) have been widely used for 
monitoring OP poisoning for the following reasons: 
(i)  They react rapidly with OP at even low concentrations,
(ii)  Good correlation exists between inhibition of esterases 
and acute sign and symptoms, 
(iii) Besides BChE being present in plasma, AChE is also 
present in human red cells, and 
(iv)  The assay methods for both the esterases are simple and 
inexpensive10,11,26.
However, susceptibility of cholinesterase is known to 
vary for different OPs due to existence of various isoenzymes 
with different turnover rates and region specificity27,28. 
Measurement of plasma BG levels has also been employed 
as a sensitive non-cholinergic biomarker of OP pesticide 
poisoning. BG and egasyn (carboxylesterase isozyme and 
Figure  6. Effect of DFP on brain reduced glutathione (GSH) 
levels of mice. Animals received various doses of DFP 
(s.c.). Control animals received equivalent amount of 
carrier. Values are mean ± SEM (n= 6). Statistically 
significant at *p< 0.05 and **p< 0.01 compared to 
corresponding control. 
Figure 7.  Effect of DFP on brain malondialdehyde (MDA) 
levels of mice. Animals received various doses of DFP 
(s.c.). Control animals received equivalent amount of 
carrier. Values are mean ± SEM (n= 6). Statistically 
significant at *p< 0.05 compared to corresponding 
control. 
Figure 9.  Representative photomicrograph of agarose gel 
electrophoresis of DNA extracted from whole brain 
of mice. Analysis was performed 14 d after exposure 
to various doses of DFP (s.c.). Control animals 
received equivalent amount of carrier. The lanes 
represent: (A) 1kb DNA ladder; (B) vehicle control; 
(C) 0.125 LD50 DFP-R1; (D) 0.125 LD50 DFP-R2; 
(E) 0.25 LD50 DFP-R1; (F) 0.25 LD50 DFP-R2; (G) 
0.50 LD50 DFP-R1; (H) 0.50 LD50 DFP-R2; (I) 1.0 
LD50 DFP-R1; (J) 1.0 LD50 DFP-R2 and (K) 1kb 
DNA ladder. 
Figure  8. Representative photomicrograph of comet assay 
performed in mice blood. (a) Control and (b) 1.0 
LD50 DFP 14 d post exposure. Magnification: 40x.
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accessory protein of BG) are known to exist as a complex in 
liver microsomal membrane. The complex can easily dissociate 
in the presence of OP to release high levels of BG into the 
plasma15,16. Measurement of antioxidants enzyme, certain 
cytogenetic biomarkers such as chromosomal aberration, sister 
chromatid exchange, DNA fragmentation and SCGE have also 
been used for the detection of exposure to commonly used OP 
pesticides11,29-31. SCGE is a micro gel electrophoresis technique 
which detects DNA damage in individual cells30. However, most 
of these studies have been limited to OP pesticide exposures, 
and not applied to more toxic OP compounds like DFP and 
nerve agents. Therefore, the present study was designed to 
evaluate dose and time- dependent effect of DFP on various 
cholinergic and non-cholinergic markers by integrating some 
of the important biomarkers discussed above. Also, it was of 
importance to see that how long the changes were appreciably 
visible, and could be employed for confirming OP exposure 
even after a lapse of time. Some of the markers could be used 
as bed side tests, while others can be measured in tissues only 
in post mortem cases for retrospective confirmation of OP 
exposure. 
OP pesticide- induced changes in animal body weight 
and relative organ-body weight ratio are known32. Also, brain 
AChE inhibition- induced down regulation of muscarinic 
receptors, decreased brain DNA synthesis, and reduced brain 
weight in offsprings are reported after chronic OP pesticide 
exposure33. However, in the present study no such phenomenon 
was observed. A significant inhibition of plasma BChE activity 
up to 24 h and brain AChE activity up to 7 d post exposure 
confirms the reliability of both the esterases in the diagnosis 
of OP poisoning. Also both the esterases exhibited a dose and 
time- dependent response to DFP. Although, percent inhibition 
of BChE was more intense compared to AChE, the effect 
on later was more lasting, indicating slower reactivation of 
AChE compared to BChE. Susceptibility of esterases to OP 
depends on their isoenzyme variants and turnover rates27,28. 
Usually, the effect of OP exposure is predominantly found in 
plasma cholinesterase34. Also, the trend of BChE and AChE 
inhibition in the present study was almost similar to another 
report19. The half- life of BChE is approximately 8 h to 16 h, 
and usually inhibition greater than 75 per cent is associated 
with neuromuscular blockade and pathophysiology10. If this 
is to be believed, then the time window in the present study 
was sufficient for the part reactivation of the inhibited enzyme 
and synthesis of the new enzyme as well. Hydrolysis is a rate-
limiting reaction by which the phosphorylated cholinesterases 
are partly reactivated1,8. 
In the present study plasma BG levels were significantly 
elevated only after lethal doses of DFP, that too only up to 1 
h post exposure. Whereas even low doses of OP pesticides 
have caused many fold increase in plasma BG levels15,16. This 
could be possibly due to difference in dissociation coefficient 
of BG-egasyn complex in case of DFP. Nevertheless, the role 
of BG as a non-cholinergic indicator of OP poisoning cannot 
be undermined. Enzymatic and non-enzymatic markers of 
oxidative stress have been shown to play a crucial role in the 
diagnosis of OP poisoning1,8,9,29. In present study, diminished 
GSH levels corroborate such findings. Although, increase in 
brain MDA levels appeared to be little delayed. Measuring the 
levels of various antioxidant enzymes would possibly ascertain 
their role in the diagnosis of OP poisoning. Our present study 
did not reveal any DNA damage, indicating that acute OP 
exposure is not likely to produce any  DNA damage unlike 
chronic OP pesticide exposures30,31.
5. CONCLUSION 
The present study indicates the relevance of measuring 
plasma BG levels together with cholinesterases to confirm acute 
OP poisoning. Also, non-specific, oxidative stress markers 
could supplement the standard biomarkers. More sensitive and 
reliable non-cholinergic biomarkers of OP poisoning remain to 
be identified in near future. This study could be of enormous 
importance to the clinicians involved in the diagnosis of OP 
poisoning. 
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